VIM0423
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for VIM0423, covering 2026-04-08 to 2026-04-08. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Tolerability of VIM0423 in Individuals With Isolated Dystonia [Phase 2]